Cambridge Cognition Holdings plc and its subsidiaries develop and commercialize computerized neuropsychological tests for sale, principally in the United Kingdom, the United States and Europe. The Company's segments include Pharmaceutical Clinical Trials, Academic Research and Healthcare Technology. The Pharmaceutical Clinical Trials segment includes products and services for use in regulated pharmaceutical clinical trials. The Academic Research segment includes cognitive test products for researchers working in a non-regulated environment, typically in academia. The Healthcare Technology segment includes medical software for use in healthcare delivery settings. The Company is a provider of validated touchscreen cognitive assessments for clinical trials. The Company's product, CANTAB Mobile is a Class II medical device, used to identify patients exhibiting the early signs of Alzheimer's disease. It also offers Cantab Insight for dementia assessment in secondary care.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Diagnostic & Testing Equipment
- Sub-Industry: N/A
- Symbol: LON:COG
- CUSIP: N/A
- Web: www.cambridgecognition.com/
- Market Cap: £23.87 million
- Outstanding Shares: 20,317,000
- 50 Day Moving Avg: GBX 118.38
- 200 Day Moving Avg: GBX 103.47
- 52 Week Range: GBX 51 - GBX 132
Sales & Book Value:
- Trailing P/E Ratio: 83.93
- P/E Growth: 0.00
- Annual Revenue: £6.88 million
- Price / Sales: 3.47
- Book Value: GBX 0.14 per share
- Price / Book: 8.39
- EBIDTA: $184,000.00
- Net Margins: 10.16%
- Return on Equity: 29.00%
- Return on Assets: 15.13%
- Average Volume: 19,817 shs.
Frequently Asked Questions for Cambridge Cognition Holdings PLC (LON:COG)
What is Cambridge Cognition Holdings PLC's stock symbol?
Cambridge Cognition Holdings PLC trades on the London Stock Exchange (LON) under the ticker symbol "COG."
Where is Cambridge Cognition Holdings PLC's stock going? Where will Cambridge Cognition Holdings PLC's stock price be in 2017?
1 analysts have issued twelve-month price targets for Cambridge Cognition Holdings PLC's shares. Their predictions range from GBX 130 to GBX 130. On average, they expect Cambridge Cognition Holdings PLC's stock price to reach GBX 130 in the next year. View Analyst Ratings for Cambridge Cognition Holdings PLC.
Who are some of Cambridge Cognition Holdings PLC's key competitors?
Some companies that are related to Cambridge Cognition Holdings PLC include Actinium Pharmaceuticals (ATNM), Amryt Pharma PLC (AMYT), Invivo Therapeutics Holdings Corp (NVIV), Redx Pharma PLC (REDX), Humanigen (KBIO), Ampio Pharmaceuticals (AMPE), ANGLE plc (AGL), Scancell Holdings Plc (SCLP), Senomyx (SNMX), CorMedix (CRMD), LiDCO Group plc (LID), Oncobiologics (ONS), Capricor Therapeutics (CAPR), Surgical Innovations Group Plc (SUN), Omega Diagnostics Group Plc (ODX), Venture Life Group PLC (VLG), Biopharmx Corp (BPMX) and Biopharmx Corp (BPMX).
Who are Cambridge Cognition Holdings PLC's key executives?
Cambridge Cognition Holdings PLC's management team includes the folowing people:
- Steven J. Powell, Chief Executive Officer, Director
- Nicholas John Cordeaux Walters, Chief Financial Officer, Secretary, Director
- Michael Lewis, Non-Executive Chairman of the Board
- Andrew D. Blackwell, Non-Executive Director
- Eric Stephen Dodd, Non-Executive Director
- Nicholas Kerton Ph.D., Non-Executive Director
How do I buy Cambridge Cognition Holdings PLC stock?
Shares of Cambridge Cognition Holdings PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Cambridge Cognition Holdings PLC's stock price today?
MarketBeat Community Rating for Cambridge Cognition Holdings PLC (LON COG)MarketBeat's community ratings are surveys of what our community members think about Cambridge Cognition Holdings PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Cambridge Cognition Holdings PLC stock can currently be purchased for approximately GBX 117.50.
Consensus Ratings for Cambridge Cognition Holdings PLC (LON:COG) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Buy Rating|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||GBX 130|
Analysts' Ratings History for Cambridge Cognition Holdings PLC (LON:COG)
(Data available from 8/22/2015 forward)
|6/7/2017||FinnCap||Reiterated Rating||Corporate||GBX 130|
|3/31/2017||Dowgate Capital||Initiated Coverage||Buy|
Earnings History for Cambridge Cognition Holdings PLC (LON:COG)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Cambridge Cognition Holdings PLC (LON:COG)
Current Year EPS Consensus Estimate: $0.64 EPS
Dividend History for Cambridge Cognition Holdings PLC (LON:COG)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Cambridge Cognition Holdings PLC (LON:COG)Insider Trades by Quarter for Cambridge Cognition Holdings PLC (LON:COG)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|6/7/2017||Andrew Damian Blackwell||Insider||Sell||131,095||GBX 109||£142,893.55|
|3/29/2017||Nicholas Anthony Kerton||Insider||Sell||150,000||GBX 78||£117,000|
|5/5/2016||Powell,Steven John||Insider||Buy||30,000||GBX 36||£10,800|
|6/5/2015||Andrew Damian Blackwell||Insider||Sell||150,000||GBX 80||£120,000|
Headline Trends for Cambridge Cognition Holdings PLC (LON:COG)
Latest Headlines for Cambridge Cognition Holdings PLC (LON:COG)
Cambridge Cognition Holdings PLC (COG) Chart for Tuesday, August, 22, 2017